Announced Wed, 22 Jul · 13:37 IST
Reg 57(5) of SEBI LODR not applicable for Q1 FY27
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.0%1-day move
₹3.05
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-2.0+0.0-1.6———————
Up moveDown movePending
AI summary
Transgene Biotek has informed BSE that SEBI LODR Regulation 57(5), which deals with payment of interest, dividend and principal on non-convertible securities, is not applicable to the company for the quarter ended 30 June 2026, because the company has not issued any non-convertible securities.
Likely market impact
Routine compliance filing confirming non-applicability. No impact on shareholders or stock price.